JoVE Logo

Accedi

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.

On the other hand, the Loo-Riegelman method estimates ka by comparing plasma concentration-time profiles following different administration routes. It provides more comprehensive data, even for drugs with multicompartment characteristics, and aids in understanding drugs' relative bioavailability and absorption characteristics. Yet, it also has limitations, such as the concentration versus time data requirement for both oral and IV drug administration of the same subject and intra-subject between oral and IV administration studies.

Tags

Wagner Nelson MethodLoo Riegelman MethodPharmacokineticsAbsorption Rate ConstantKa EstimationPlasma ConcentrationOne compartment KineticsGastrointestinal MotilityEnzymatic DegradationBioavailabilityMulticompartment CharacteristicsConcentration time Profiles

Dal capitolo 7:

article

Now Playing

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

282 Visualizzazioni

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

70 Visualizzazioni

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

62 Visualizzazioni

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

132 Visualizzazioni

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

146 Visualizzazioni

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

51 Visualizzazioni

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

130 Visualizzazioni

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

46 Visualizzazioni

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

178 Visualizzazioni

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

108 Visualizzazioni

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

72 Visualizzazioni

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

83 Visualizzazioni

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

309 Visualizzazioni

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

182 Visualizzazioni

article

7.15 : Two-Compartment Open Model: Extravascular Administration

Pharmacokinetic Models

124 Visualizzazioni

See More

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati